XML 38 R22.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholder Equity (Tables)
3 Months Ended
Mar. 31, 2025
Stockholder Equity  
Schedule of stock option activity

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

 

 

 

Average

 

 

Aggregate

 

 

Remaining

 

 

 

Shares

 

 

Exercise

Price

 

 

Intrinsic

Value

 

 

Contractual

Life (Years)

 

Options outstanding at December 31, 2024

 

 

15,843,116*

 

$0.94

 

 

$3,324,000

 

 

 

5.95

 

Granted

 

 

908,659

 

 

 

0.66

 

 

 

-

 

 

 

-

 

Exercised

 

 

(200,000)

 

 

0.12

 

 

 

-

 

 

 

-

 

Expired/forfeit

 

 

(142,713)

 

 

2.96

 

 

 

-

 

 

 

-

 

Options outstanding at March 31, 2025

 

 

16,409,062*

 

$0.92

 

 

$1,274,000

 

 

 

5.98

 

Options Exercisable at March 31, 2025

 

 

8,150,185*

 

$0.60

 

 

$1,274,000

 

 

 

2.74

 

Schedule of stock option assumtion

 

 

March 31,

 

 

March 31,

 

 

 

2025

 

 

2024

 

Expected volatility

 

67.81 – 69.25%

 

 

26.36 – 26.38%

 

Expected term (years)

 

6.25 Years

 

 

6.25 Years

 

Risk-free rate

 

4.14 - 4.51%

 

 

4.09 – 4.31%

 

Dividend rate

 

 

0.00%

 

0.00%

Schedule of outstanding nonvested restricted stock

 

 

 

 

 

Weighted-

Average

 

 

 

 

 

 

Grant Date

 

 

 

Amount

 

 

Fair Value

 

Nonvested, beginning of the year

 

 

3,549,292

 

 

$1.23

 

Granted

 

 

2,382,284

 

 

 

0.62

 

Vested

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

Nonvested, end of the year

 

 

5,931,576

 

 

$0.98

 

Schedule of warrant activity

 

 

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Aggregate

Intrinsic

Value

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

Outstanding and exercisable at December 31, 2024

 

 

14,675,244

 

 

 

1.13

 

 

$-

 

 

 

4.88

 

Issued

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Outstanding and exercisable at March 31, 2025

 

 

14,675,244

 

 

 

1.13

 

 

$-

 

 

 

4.63